| 查看: 1370 | 回复: 13 | |||
[交流]
美国 University of Nebraska-Lincoln 全奖招博士研究生 (Biomedical area)
|
|
Dr. Jiujiu Yu from the Department of Nutrition and Health Sciences at the University of Nebraska Lincoln is recruiting a highly-motivated Ph.D. student for Fall 2022. Our broad research interests are to 1) investigate the molecular mechanisms of NLRP3 inflammasome activation in the innate immune cells; 2) study the role of NLRP3 inflammasome-mediated chronic inflammation in obesity, aging, and liver diseases; and 3) identify new molecular nutraceuticals to suppress such inflammation (https://cehs.unl.edu/nhs/yu-lab/). Minimum qualification includes an M.S. or equivalent degree in biology, biochemistry, nutrition, or related field. Previous research experience in one or more of the following areas (obesity, liver diseases, extracellular vesicles, dietary molecules, mouse models, microbiome) is highly desirable. If interested, please submit your CV and personal statement to Dr. Yu at jyu18@unl.edu please indicate your GPA, TOEFL, and GRE scores in your application. Your application will not be considered without a personal statement or the aforementioned scores. Department requirement: Grade point average of 3.0 or higher on a 4.0 scale. Preferred minimum GRE scores: 145 Verbal; 150 Quantitative; 3.0 Analytical (writing). Required minimum TOEFL score (International students only): 550 paper; 79 internet; or 6.5 IELTS. https://cehs.unl.edu/nhs/graduate-programs/#tab0 |
» 猜你喜欢
A区一本交叉课题组,低分调剂,招收机械电子信息通信等交叉方向
已经有22人回复
招调剂
已经有7人回复
0703 东华大学 理学化学均过 a 线,总分 281 求调剂
已经有8人回复
材料学硕318求调剂
已经有21人回复
271求调剂
已经有5人回复
328求调剂
已经有5人回复
080500材料科学与工程
已经有11人回复
成果系统访问量大,请15分钟后再尝试。由此给您造成的不便,敬请谅解。
已经有17人回复
282求调剂
已经有4人回复
304求调剂
已经有4人回复
蝉123456
新虫 (知名作家)
- 应助: 0 (幼儿园)
- 金币: 8621.2
- 散金: 7624
- 沙发: 17
- 帖子: 8492
- 在线: 80.3小时
- 虫号: 25711072
- 注册: 2021-03-08
- 专业: 计算机软件
2楼2022-02-03 19:32:33
3楼2022-02-05 06:09:36
4楼2022-02-06 11:46:10
5楼2022-02-07 01:41:04
6楼2022-02-09 03:10:13
7楼2022-02-10 03:58:07
8楼2022-02-10 23:34:59
9楼2022-02-12 00:00:36
10楼2022-02-13 08:50:05













回复此楼